A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection
Public ClinicalTrials.gov record NCT01022346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study of the Safety and Response Rate of 3 Subcutaneously Administered Doses of 5 X 10^7 PFU RO5217790 in Patients With High Grade Cervical Intraepithelial Neoplasia Grade 2 or 3 Associated With High Risk HPV Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, double-blind, placebo-controlled, parallel arm study will assess the safety and the efficacy of RO5217790 on histologic resolution in participants with high grade CIN associated with HR-HPV infection. Participants will be randomized to receive 3 subcutaneous injections of either placebo or RO5217790 on Days 1, 8, and 15. Study assessments will be made at Baseline, at Month 3 and 6, and every 6 months thereafter for an overall of 2.5 years.
Study identification
- NCT ID
- NCT01022346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 206 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Sep 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Aug 15, 2016
2009 – 2013
United States locations
- U.S. sites
- 43
- U.S. states
- 24
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | 36608 | — |
| Not listed | Phoenix | Arizona | 85015 | — |
| Not listed | Phoenix | Arizona | 85032 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Tucson | Arizona | 85724-5078 | — |
| Not listed | Colton | California | 92324 | — |
| Not listed | Los Angeles | California | 90027 | — |
| Not listed | Colorado Springs | Colorado | 80910 | — |
| Not listed | Stamford | Connecticut | 06904 | — |
| Not listed | Washington D.C. | District of Columbia | 20010 | — |
| Not listed | Lake Worth | Florida | 33461 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Plantation | Florida | 33324 | — |
| Not listed | Sarasota | Florida | 34239 | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | West Palm Beach | Florida | 33409 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Augusta | Georgia | 30912 | — |
| Not listed | Decatur | Georgia | 30034 | — |
| Not listed | Marrero | Louisiana | 70072 | — |
| Not listed | Framingham | Massachusetts | 01702 | — |
| Not listed | Kansas City | Missouri | 64139 | — |
| Not listed | Lincoln | Nebraska | 68510 | — |
| Not listed | Las Vegas | Nevada | 89030 | — |
| Not listed | Las Vegas | Nevada | 89128 | — |
| Not listed | Lawrenceville | New Jersey | 08648 | — |
| Not listed | Brightwaters | New York | 11718 | — |
| Not listed | The Bronx | New York | 10461 | — |
| Not listed | New Bern | North Carolina | 28562 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Englewood | Ohio | 45322 | — |
| Not listed | Gallipolis | Ohio | 45631 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | West Reading | Pennsylvania | 19611 | — |
| Not listed | Columbia | South Carolina | 29201 | — |
| Not listed | Greenville | South Carolina | 29615 | — |
| Not listed | Myrtle Beach | South Carolina | 29572 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | McAllen | Texas | 78503 | — |
| Not listed | Sandy City | Utah | 84070 | — |
| Not listed | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01022346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 15, 2016 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01022346 live on ClinicalTrials.gov.